<DOC>
	<DOCNO>NCT02221271</DOCNO>
	<brief_summary>Patients diagnose Guillain-Barré syndrome confirm base diagnostic criterion Guillain-Barré syndrome . Patients meet inclusion criterion conflict exclusion criterion receive NPB-01 ( intravenous immunoglobulin ) 400mg/kg/day five consecutive day . Patients evaluate Functional Grade（FG） Arm Grade（AG） et al . As safety endpoint , safety NPB-01 investigate occurrence adverse event start study treatment .</brief_summary>
	<brief_title>Phase III Clinical Trial NPB-01 Patients With Guillain-Barré Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Guillain-Barre Syndrome</mesh_term>
	<criteria>1 . In principle , patient able receive study drug within 2weeks ( limit 4weeks ) start symptom . 2 . Patients predominant motor neuropathy Hughes 's Functional Grade ( FG ) grade4 grade5 ( regard , symptom progressive , patient FG grade3 involve study ) . 3 . Patients plasmapheresis , steroid ( prednisolone equivalent , 100mg/day ) immune globulin therapy operation onset . 4 . Patients great equal 18 year old informed consent . 1 . Patients history shock NPB01 . 2 . Patients history hypersensitivity NPB01 . 3 . Patients history volatile organic solvent abuse , abnormal porphyrin metabolism , history pharynx cutaneous diphtheria , plumbism , tephromyelitis , botulism , hysterical paralysis , toxic neuropathy ( nitrofurantoin , dapsone , organophosphorous compound ) , serious diabetic neuropathy , peripheral neuropathy due HIV , impaired peripheral neuropathy except GuillainBarré syndrome . 4 . Patients malignancy inform consent . 5 . Patients treat immune globulin 8 week inform consent . 6 . Patients IgA deficiency . 7 . Patients impaired liver function . 8 . Patients impaired renal function . 9 . Patients cerebro cardiovascular disorder . 10 . Patients high risk thromboembolism . 11 . Patients hemolytic/hemorrhagic anemia . 12 . Patients decrease cardiac function . 13 . Patients decreased platelet .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>